Literature DB >> 12763241

Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice.

Luc Taillandier1, Laurent Antunes, K S Angioi-Duprez.   

Abstract

To study the optimum therapeutic modalities for treating human malignant brain tumors in vivo without ethical limitations, a model of heterotopic and another of orthotopic xenografting into nude mice were developed. For the first implantation, 11 human high-grade gliomas and 4 low-grade tumors were microsurgically grafted on epigastric vessels. The 11 high-grade gliomas, but no low-grade tumors, were established into nude mice. Afterwards, all these mouse-adapted gliomas which grafted into other nude mice developed. Introduction of a microcatheter into the femoral artery or vein permitted infusion for magnetic resonance imaging (MRI) and treatment. A bladder catheter setting and electrode implantation allowed urine sampling and ECG or EEG recording. Thus, the most important parameters of chemo- and radiotherapy to destroy a maximum number of malignant cells or to inhibit their divisions and the hosts reactions to treatment can be studied. The human gliomas transplanted onto the mouse brain infiltrated the host brain at great distances from the tumor, as in human patients. So, this second implantation constitutes a representative model of the evolution of human gliomas, and allows the study of malignant cell migration in the brain before, during and after treatment determined with the heterotopic model and to appreciate the tolerance of the colonized brain to these treatments. Echography and MRI allowed us to follow the macroscopic evolution with or without treatment of the malignant brain tumors transplanted onto mouse brains. It should now be possible to undertake the same clinical studies on patients after appropriate consideration of ethical and scientific constraints.

Entities:  

Mesh:

Year:  2003        PMID: 12763241     DOI: 10.1016/s0165-0270(03)00043-8

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  19 in total

1.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 2.  MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trials.

Authors:  A R Borges; P Lopez-Larrubia; J B Marques; S G Cerdan
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

3.  Reduction of image artifacts in mice by bladder flushing with a novel double-lumen urethral catheter.

Authors:  Chad R Haney; Adrian D Parasca; Kazuhiro Ichikawa; Benjamin B Williams; Martyna Elas; Charles A Pelizzari; Howard J Halpern
Journal:  Mol Imaging       Date:  2006-07       Impact factor: 4.488

4.  Antitumor treatment efficacy by targeting epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in an orthotopic human glioblastoma model.

Authors:  Diao Yi; Tian Xin Hua; Huang Yan Lin; Chen Lu Kui; Lin Xiao Ning; Zhuang Zai Wang
Journal:  J Neurooncol       Date:  2010-12-08       Impact factor: 4.130

5.  Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.

Authors:  Marie Jarry; Céline Lecointre; Céline Malleval; Laurence Desrues; Marie-Thérèse Schouft; Vadim Lejoncour; François Liger; Gildas Lyvinec; Benoît Joseph; Nadège Loaëc; Laurent Meijer; Jérôme Honnorat; Pierrick Gandolfo; Hélène Castel
Journal:  Neuro Oncol       Date:  2014-06-02       Impact factor: 12.300

6.  High-resolution longitudinal screening with magnetic resonance imaging in a murine brain cancer model.

Authors:  Nicholas A Bock; Gelareh Zadeh; Lori M Davidson; Baoping Qian; John G Sled; Abhijit Guha; R Mark Henkelman
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

7.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

Review 8.  In vivo models of primary brain tumors: pitfalls and perspectives.

Authors:  Peter C Huszthy; Inderjit Daphu; Simone P Niclou; Daniel Stieber; Janice M Nigro; Per Ø Sakariassen; Hrvoje Miletic; Frits Thorsen; Rolf Bjerkvig
Journal:  Neuro Oncol       Date:  2012-06-07       Impact factor: 12.300

9.  Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar.

Authors:  Xi Feng Fei; Quan Bin Zhang; Jun Dong; Yi Diao; Zhi Min Wang; Ru Jun Li; Zi Cheng Wu; Ai Dong Wang; Qing Lan; Shi Ming Zhang; Qiang Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-29

10.  Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?

Authors:  Stéphane Kremer; Sophie Pinel; Pierre-Olivier Védrine; Aude Bressenot; Philippe Robert; Serge Bracard; François Plénat
Journal:  J Neurooncol       Date:  2007-04-19       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.